Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

ICL, Elbit, Bank Leumi, Gazit-Globe: Israeli Equity Preview

Sept. 6 (Bloomberg) -- The following stocks may rise or fall in Israeli markets. Stock symbols are in parentheses after the company names and prices are from the last close unless otherwise stated.

The TA-25 Index lost 1.9 percent to 1,062.36 in Tel Aviv.

Alony Hetz Properties & Investment Ltd. (ALHE IT): The real-estate investment company said it raised gross proceeds of 331.5 million shekels ($91 million) from a bond sale. Alony Hetz declined 0.7 percent to 16.89 shekels.

Gazit-Globe Ltd. (GLOB IT): The real-estate investment company said it raised 451 million shekels in gross proceeds from a sale of Series Yud Aleph bonds. Gazit-Globe fell 1.7 percent to 35.41 shekels.

Elbit Systems Ltd. (ESLT IT): A U.S. unit of Israel’s largest non-government defense contractor won a contract to supply Boeing Co. with helmet displays. Elbit retreated 1.2 percent to 136 shekels.

Israel Chemicals Ltd. (ICL IT): Israel is mulling the establishment of a panel to review the royalties on Dead Sea Works Ltd., a unit of the company that extracts minerals from the Dead Sea to make fertilizer. Israel Chemicals plunged 7.2 percent to 46 shekels.

Bank Leumi Le-Israel Ltd. (LUMI IT): Moody’s Midroog assigned an Aa1 rating to as much as 2.5 billion shekels of deferred notes the country’s largest lender by assets may sell. Bank Leumi dropped 2.4 percent to 12.32 shekels.

Melisron Ltd. (MLSR IT): The commercial-real estate company said its board authorized management to pursue a bond sale. Melisron advanced 0.2 percent to 65.50 shekels.

To contact the reporter on this story: {Sharon Wrobel} in Tel Aviv at swrobel4@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.